Buprenorphine Tablet
Product Images NDC 70518-1557

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 70518-1557). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 2mg 70518 1557 00

Buprenorphine 2mg 70518 1557 00
Label for Buprenorphine Sublingual Tablet C-III, 2 mg strength, in a 30-tablet package by RemedyRepack Inc. The label includes storage instructions (20-25°C, with excursions permitted to 15-30°C), a caution about federal law prohibiting drug transfer, and contact information for the repackager in Indiana, PA.*
FDA Label Image

Buprenorphine 2mg 70518 1557 01

Buprenorphine 2mg 70518 1557 01
Label for Buprenorphine Sublingual Tablet C-III, 2 mg strength, repackaged by RemedyRepack Inc. The label indicates a quantity of 50 tablets per box and provides storage instructions (20-25°C, with excursions 15-30°C). It includes warnings about federal transfer regulations and child safety, along with contact details for RemedyRepack Inc. The label also displays the original manufacturer's NDC and location.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Buprenorphine Sublingual Tablet C-III, 2 mg strength, containing 1 tablet. The label includes the NDC number 70518-1557-02 and indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and a federal caution about transfer restrictions are also present.*
FDA Label Image

Image Opava 1

Image Opava 1
Chemical structure of Buprenorphine hydrochloride, showing its molecular framework with labeled functional groups and bonds.*
FDA Label Image

Image Opava 4

Image Opava 4
An instructional illustration showing a hand placing a tablet sublingually under the tongue inside an open mouth. The image demonstrates the proper administration method for a sublingual tablet form of medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.